Cargando…
Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis
BACKGROUND: Hypertension and proteinuria are critically involved in the progression of chronic kidney disease. Despite treatment with renin angiotensin system inhibition, kidney function declines in many patients. Aldosterone excess is a risk factor for progression of kidney disease. Hyperkalaemia i...
Autores principales: | Currie, Gemma, Taylor, Alison H. M., Fujita, Toshiro, Ohtsu, Hiroshi, Lindhardt, Morten, Rossing, Peter, Boesby, Lene, Edwards, Nicola C., Ferro, Charles J., Townend, Jonathan N., van den Meiracker, Anton H., Saklayen, Mohammad G., Oveisi, Sonia, Jardine, Alan G., Delles, Christian, Preiss, David J., Mark, Patrick B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015203/ https://www.ncbi.nlm.nih.gov/pubmed/27609359 http://dx.doi.org/10.1186/s12882-016-0337-0 |
Ejemplares similares
-
Proteinuria and its relation to cardiovascular disease
por: Currie, Gemma, et al.
Publicado: (2013) -
The Kidneys and Aldosterone/Mineralocorticoid Receptor System in Salt-Sensitive Hypertension
por: Shibata, Shigeru, et al.
Publicado: (2011) -
Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria
por: Currie, Gemma E., et al.
Publicado: (2018) -
Why are mineralocorticoid receptor antagonists cardioprotective?
por: Chai, Wenxia, et al.
Publicado: (2006) -
Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial
por: Lindhardt, Morten, et al.
Publicado: (2016)